|
Bio sector buys expertise
"There are plenty of biopharmaceuticals in the pipeline,
so there is plenty of growth potential. Small companies in
the bio field in particular are seeking to outsource the production
operations needed for clinical trials," says Pirkko Suhonen,
the CEO of Medipolis GMP Ltd.
Medipolis GMP, which provides production and process development
services in biopharmaceuticals, specializes in microbial fermentation
i.e. producing biopharmaceuticals in bacteria.
Medipolis GMP Ltd, which was established in 2001, is a company
whose roots date back to development activities in the bio
field in Oulu at the end of the 1990s. There is no other operator
exactly similar in Finland, although contract manufacturing
as a business activity is widespread in the bio sector and
there are several providers of the service.
"Awareness of Medipolis has gradually increased - thanks
to successful customer projects in which drugs have been produced
successfully for clinical trials," Suhonen says.
Customers sought worldwide
Medipolis's customers are companies that develop biopharmaceuticals
and need a drug for clinical trials. In particular, they are
small companies which themselves do not have expertise in
industrial production or the relevant skills in a quality
system for drug production.
Potential customer projects are found mainly abroad. Projects
are being sought on international markets and they can, Suhonen
says, in principle come from anywhere in the world. At this
moment the core market is Europe, especially Scandinavia,
western Europe and Great Britain. The United States is the
most important market for the biopharmaceuticals sector.
The contract manufacturing market for biopharmaceuticals
is worth about 1.7 billion US dollars. By 2009 it is expected
to have grown to about 4 billion dollars.
"The market is divided among several technologies, but
there is growth potential. I believe that we will be able
to grow with the market by specializing and acquiring our
own specialized skills and recognition as a reliable supplier,"
Suhonen says.


>>
www.medipolisgmp.com
|